Literature DB >> 17093399

Application of multiplex cytometric bead array technology for the measurement of angiogenic factors in the vitreous.

Richard Maier1, Martin Weger, Eva-Maria Haller-Schober, Yosuf El-Shabrawi, Anna Theisl, Alfred Barth, Reingard Aigner, Anton Haas.   

Abstract

PURPOSE: This study was carried out to compare cytometric bead array (CBA) technology with conventional enzyme linked immunosorbent assay (ELISA) for the measurement of both vitreous and serum concentrations of interleukin-8 (IL-8), vascular endothelial growth factor (VEGF), and angiogenin (ANG) in diabetic and non-diabetic patients.
METHODS: Measurement of vitreous and serum concentrations of IL-8, VEGF, and ANG using both ELISA and CBA was performed in 26 probands (13 diabetics and 13 non-diabetic control subjects).
RESULTS: Vitreous and serum concentrations of IL-8, VEGF, and ANG determined by CBA showed a strong correlation with those measured by ELISA. Vitreous levels of IL-8, VEGF, and ANG were significantly higher in diabetics compared to non-diabetic control subjects. No significant correlation between vitreous and serum levels of any of the investigated parameters were found in either diabetics or control individuals.
CONCLUSIONS: The present study is the first to utilize cytometric bead array technology for the measurement of angiogenic factors in the vitreous. Measurements obtained by ELISA and CBA technologies were highly correlated for IL-8, VEGF, and ANG in both vitreous and serum samples. Diabetic individuals showed significant elevation of IL-8, VEGF, and ANG in the vitreous but not in serum samples compared to control subjects. The most striking advantage of the CBA technology is the fact that numerous parameters can be measured in parallel using a comparatively small sample volume. It is therefore more rapid and cost effective than ELISA technology. CBA technology is a new, accurate method to measure IL-8, VEGF, and ANG in the vitreous.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093399

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  13 in total

1.  Vascular endothelial growth factor acts primarily via platelet-derived growth factor receptor α to promote proliferative vitreoretinopathy.

Authors:  Steven Pennock; Luis J Haddock; Shizuo Mukai; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2014-09-26       Impact factor: 4.307

2.  Angiogenin in age-related macular degeneration.

Authors:  Jessica M Skeie; Shemin Zeng; Elizabeth A Faidley; Robert F Mullins
Journal:  Mol Vis       Date:  2011-02-23       Impact factor: 2.367

3.  [Cytokine determination from vitreous samples in retinal vascular diseases].

Authors:  M Pfister; F H Koch; J Cinatl; F Rothweiler; R Schubert; P Singh; H Ackermann; M J Koss
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

Review 4.  The Vitreous Ecosystem in Diabetic Retinopathy: Insight into the Patho-Mechanisms of Disease.

Authors:  Siva S R Iyer; Mollie K Lagrew; Stephanie M Tillit; Ramak Roohipourmoallai; Samuel Korntner
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

5.  Inflammatory and angiogenic protein detection in the human vitreous: cytometric bead assay.

Authors:  M J Koss; M Pfister; F H Koch
Journal:  J Ophthalmol       Date:  2011-12-27       Impact factor: 1.909

6.  Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration.

Authors:  Devon H Ghodasra; Ryan Fante; Thomas W Gardner; Michael Langue; Leslie M Niziol; Cagri Besirli; Steven R Cohen; Vaidehi S Dedania; Hakan Demirci; Nieraj Jain; K Thiran Jayasundera; Mark W Johnson; Partho S Kalyani; Rajesh C Rao; David N Zacks; Jeffrey M Sundstrom
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-06-01       Impact factor: 4.799

7.  Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients.

Authors:  Richard Maier; Martin Weger; Eva-Maria Haller-Schober; Yosuf El-Shabrawi; Andreas Wedrich; Anna Theisl; Reingard Aigner; Alfred Barth; Anton Haas
Journal:  Mol Vis       Date:  2008-03-27       Impact factor: 2.367

8.  Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy.

Authors:  Mojca Globocnik Petrovic; Peter Korosec; Mitja Kosnik; Josko Osredkar; Marko Hawlina; Borut Peterlin; Daniel Petrovic
Journal:  Mol Vis       Date:  2008-07-30       Impact factor: 2.367

9.  IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome.

Authors:  Hayato Maruoka; Daichi Inoue; Yoko Takiuchi; Seiji Nagano; Hiroshi Arima; Sumie Tabata; Akiko Matsushita; Takayuki Ishikawa; Tatsuo Oita; Takayuki Takahashi
Journal:  Ann Hematol       Date:  2013-08-25       Impact factor: 3.673

10.  Measurement of tumor necrosis factor-alpha, interleukin-6, Fas ligand, interleukin-1α, and interleukin-1β in the aqueous humor of patients with open angle glaucoma using multiplex bead analysis.

Authors:  Andreas Borkenstein; Christoph Faschinger; Richard Maier; Martin Weger; Anna Theisl; Ulrike Demel; Winfried Graninger; Holzer Irene; Georg Mossböck
Journal:  Mol Vis       Date:  2013-11-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.